Clinical Trial Detail

NCT ID NCT01032148
Title Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements no
Sponsors Roswell Park Cancer Institute
Indications

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

Panobinostat

Age Groups: adult

No variant requirements are available.